Modulators of hemoglobin
US11014884B2 · kind B2 · utility
0Cited by
57References
60Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 2019 |
| Grant date | May 25, 2021 |
| Priority date | — |
| Expiry date | Sep 30, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.